BlackRock’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BlackRock’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.7M	Buy	516,032 +367,215	+247%	+$49.6M	﹤0.01%	2347
2026 Q1	$19M	Sell	148,817 -83,975	-36%	-$10.5M	﹤0.01%	3117
2025 Q4	$28.4M	Sell	232,792 -22,993	-9%	-$2.64M	﹤0.01%	2877
2025 Q3	$25.6M	Buy	255,785 +25,280	+11%	+$2.28M	﹤0.01%	2933
2025 Q2	$19.1M	Buy	230,505 +13,974	+6%	+$1.11M	﹤0.01%	3060
2025 Q1	$17.6M	Sell	216,531 -261,207	-55%	-$23.3M	﹤0.01%	3010
2024 Q4	$43M	Buy	477,738 +40,909	+9%	+$3.96M	﹤0.01%	2548
2024 Q3	$43.2M	Sell	436,829 -14,582	-3%	-$1.43M	﹤0.01%	2557
2024 Q2	$41.9M	Sell	451,411 -40,623	-8%	-$3.64M	﹤0.01%	2529
2024 Q1	$46.7M	Sell	492,034 -41,914	-8%	-$3.89M	﹤0.01%	2468
2023 Q4	$47.7M	Sell	533,948 -18,044	-3%	-$1.34M	﹤0.01%	2502
2023 Q3	$40.3M	Sell	551,992 -11,050	-2%	-$883K	﹤0.01%	2527
2023 Q2	$46.8M	Sell	563,042 -22,631	-4%	-$1.89M	﹤0.01%	2526
2023 Q1	$44.6M	Sell	585,673 -79,245	-12%	-$6.58M	﹤0.01%	2528
2022 Q4	$55.2M	Buy	664,918 +50,970	+8%	+$4.13M	﹤0.01%	2391
2022 Q3	$48.7M	Buy	613,948 +142,837	+30%	+$12M	﹤0.01%	2453
2022 Q2	$35M	Buy	471,111 +467,361	+12,463%	+$35.1M	﹤0.01%	2735
2022 Q1	$337K	Sell	3,750 -6	-0.2%	-$554	﹤0.01%	4980
2021 Q4	$421K	Buy	3,756 +6	+0.2%	+$724	﹤0.01%	4924
2021 Q3	$471K	Hold	3,750	–	–	﹤0.01%	4771
2021 Q2	$508K	Hold	3,750	–	–	﹤0.01%	4691
2021 Q1	$509K	Hold	3,750	–	–	﹤0.01%	4608
2020 Q4	$528K	Hold	3,750	–	–	﹤0.01%	4339
2020 Q3	$418K	Hold	3,750	–	–	﹤0.01%	4294
2020 Q2	$420K	Buy	+3,750	New	+$369K	﹤0.01%	4243
2020 Q1	–	Sell	-2	Closed	–	–	5099
2019 Q4	$0	Sell	2 -15	-88%	-$1.3K	﹤0.01%	5087
2019 Q3	$1K	Buy	+17	New	+$1.41K	﹤0.01%	4950

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BlackRock's XBI Position: Q2 2026 in Review

BlackRock increased its State Street SPDR S&P Biotech ETF (XBI) stake by 247% in Q2 2026, buying an estimated $49.6M and bringing the position to 516,032 shares worth $81.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

BlackRock first reported a position in XBI in Q3 2019 and has held it in 27 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

BlackRock held 516,032 shares of State Street SPDR S&P Biotech ETF worth $81.7M as of Q2 2026.
BlackRock bought 367,215 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $49.6M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2347 holding.
BlackRock first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 27 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.